Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.46 |
| ▸ | MEN1 | O00255 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.46 |
| ▸ | CFTR | P13569 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 2/20 | 0.41 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | CA9 | Q16790 | 2/20 | 0.41 |
| ▸ | CA5A | P35218 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3070118 | 0.86 | KMT2A (0.57) | TSHRLMNAKMT2AALDH1A1HSD17B10 | |
| SCHEMBL8900113 | 0.85 | KDM4E (0.51) | TSHRLMNAKMT2AMEN1ALDH1A1 | |
| SCHEMBL17659280 | 0.84 | PLA2G2A (0.47) | TSHRLMNAKMT2AMEN1ALDH1A1 | |
| SCHEMBL14340699 | 0.83 | KMT2A (0.49) | TSHRLMNAKMT2AMEN1ALDH1A1 | |
| SCHEMBL13353027 | 0.82 | KMT2A (0.57) | TSHRLMNAKMT2AALDH1A1HSD17B10 | |
| SCHEMBL8898801 | 0.81 | MEN1 (0.50) | TSHRLMNAKMT2AMEN1ALDH1A1 | |
| SCHEMBL8834699 | 0.81 | KMT2A (0.47) | TSHRLMNAKMT2AMEN1ALDH1A1 | |
| SCHEMBL28485212 | 0.80 | GABRA1 (0.43) | TSHRLMNAKMT2AMEN1ALDH1A1 | |
| SCHEMBL14691040 | 0.79 | KMT2A (0.50) | TSHRLMNAKMT2AMEN1ALDH1A1 | |
| SCHEMBL7811751 | 0.79 | NPSR1 (0.48) | TSHRLMNAKMT2AALDH1A1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7932463-B2 | Quinacridine derivatives and organic electronic devices using the same | LG CHEM, LTD. (KR) | 2011-04-26 | — | — | US | disclosed |
| US-7932463-B2 | Quinacridine derivatives and organic electronic devices using the same | LG CHEM, LTD. (KR) | 2011-04-26 | — | — | US | disclosed |
| US-20090165848-A1 | Quinacridine Derivatives and Organic Electronic Devices Using the Same | LG CHEM. LTD. (KR) | 2009-07-02 | — | — | US | disclosed |
| US-20090165848-A1 | Quinacridine Derivatives and Organic Electronic Devices Using the Same | LG CHEM. LTD. (KR) | 2009-07-02 | — | — | US | disclosed |
| EP-1164178-B1 | Electroluminescent devices having arylamine polymers | EASTMAN KODAK CO (US) | 2003-09-03 | — | — | EP | disclosed |
| EP-1164178-A1 | Electroluminescent devices having arylamine polymers | EASTMAN KODAK COMPANY (US) | 2001-12-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090165848-A1 | Quinacridine Derivatives and Organic Electronic Devices Using the Same | NQO2, QARS1, DDT | TSHR 4550/4885LMNA 4154/4885KMT2A 690/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.